ArticleCancer immunology research2015
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.
David M Woods et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
289 papers cite itlatest 60 shown
this paperpooled ittrialcites it